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Introduction
Parkinson's disease is characterized neuropathologically both by death of substantia nigra dopamine neurons and the progressive accumulation of pathological inclusions in widespread parts of the nervous system [19] . These inclusions, named Lewy bodies and Lewy neurites, are mainly composed of misfolded alpha-synuclein (syn) [18; 19] and they engage an increasing number of brain regions as the disease progresses over several years. This spreading of Lewy pathology in the brain follows a stereotypical pattern and has been suggested to first start in the olfactory system and the dorsal motor nucleus of the vagus [4; 5; 6; 7; 8; 15] . The brain regions that sequentially develop Lewy pathology in PD are all interconnected, an observation that provided some of the scientific premise for the hypothesis that syn aggregates can propagate from one neuron to another via neural connections [1; 4; 10; 21] .
Extensive work using in vitro models has subsequently demonstrated that misfolded syn can act as a template and impose its aberrant conformation to native syn, and that the seeds of misfolded syn can be released and taken up by neighboring cells that in turn develop syn inclusions [11; 20; 40; 44] . Thus, misfolded syn itself could be a vector of propagation and could underlie a propagation of synucleinopathy between brain regions in humans [11; 37] . To address this hypothesis, several groups have tested the seeding and prion-like spreading of pathological syn in vivo [13; 14; 37] . Intracerebral or peripheral injection of recombinant syn J o u r n a l P r e -p r o o f 4 fibrils or syn aggregates derived from brain lysates from post-mortem patients with synucleinopathy can induce syn aggregation in both animals overexpressing syn and in wild type animals [11; 14; 24; 32; 37] .
Several previously published studies have focused on defining the development of abnormal syn inclusions following injections into the striatum or in the substantia nigra, which exhibit synucleinopathy only in advanced PD. By contrast, recent reports from our group have focused on triggering synucleinopathy in the olfactory bulb because it is believed to be one of the first brain regions affected in PD [34; 35; 36; 37] . By unilateral stereotaxic injection of recombinant syn fibrils into the olfactory bulb of wild type mice, we have demonstrated syn aggregation is initially triggered at the site of injection and then it progressively spreads sequentially to interconnected brain regions [34; 36] . Our published observations strongly suggest propagation via a neuronal network, but they do not completely rule out other spreading routes such as local diffusion, or migration of glia containing seeds [33] . Indeed, some reviews of the literature to date on syn pathology spread question whether the propagate via neural connectivity [40] and suggest that given inconsistencies in the transsynaptic spread literature, perhaps cell-type specific explanations might provide a better explanation [42] for observed pathology proliferation patterns.
To further define the anatomical patterns and dynamics of the spread of syn inclusions, and thereby gain greater insight into the role of neural connections, here we reanalyze our own data with a specific focus on network transmission of inclusions. For this purpose, we use our recently developed mathematical model called Directional Network Transmission (DNT) [26; 27] , which we have previously demonstrated can predict tau pathology transmission in the mouse brain, but does not well represent a progression. In turn, this model was based on our original J o u r n a l P r e -p r o o f J o u r n a l P r e -p r o o f the olfactory bulb with syn pre-formed fibrils (PFFs) made of recombinant wild-type mouse syn PFFs (mPFFs) or wild-type human syn PFFs (huPFFs). The mice were sacrificed via transcardial perfusion with 4% paraformaldehyde in groups at either 1, 3, 6, 9, 12, or 18 months post-injection. The entire brains were sectioned coronally on a microtome into 30 µm thick sections in 8 series. Free-floating sections were stored in cryoprotectant until use. We stained every 8 th section of the entire brain with Ab51253 (Abcam) for syn phosphorylated on Serine 129, a marker of pathological syn [2; 33; 34; 36] . Endogenous peroxidase were blocked by incubation with 3% H 2 O 2 for 20 min. Sections were then blocked in 10% normal goat serum, 0.3% triton x100, 0.4% Bovine serum albumin; followed by overnight incubation with rabbit anti pser129 antibody (1/10000 in 2% normal goat serum, 0.3% triton X100). We incubated the sections with secondary antibody goat anti-rabbit biotinylated (1:500, Vector lab) in blocking solution. Sections were then incubated for 1hour in ABC (ABC Kit, Vector lab) and revealed using DAB kit (Vector lab).
These sections were blind coded and were analyzed at x20 using Nikon eclipse Ni-U microscope. We semi-quantitatively rated syn inclusions on a 0-4 scale (one score per brain region) based on relative abundance of pser129 inclusions: 0=no aggregates; 1=sparse: very few neurites, max 1 soma; 2=mild inclusions; 3=dense inclusions; 4=very dense inclusions) for 4 mice per group at 1 month post-injection, 4 mPFF and 3 huPFF injected mice at 3 months, 5 mPFF and 4 huPFF injected mice at 6 months, 3 mPFF and 5 huPFF injected mice at 9 months, 7 mPFF and 5 huPFF injected mice at 12 months, and 5 huPFF and 3 mPFF injected mice at 18 months. Mouse brain regions were manually identified using the Paxinos and Franklin mouse brain atlas [29] . The list of the brain regions where syn inclusions were detected can be found in the original publications [34; 36] . Importantly, the staining conditions used would detect only J o u r n a l P r e -p r o o f dense pser129-positive inclusions and we have shown previously [34; 36] that these inclusions shared the markers for pathological syn aggregates (colocalization with p62, ubiquitin and Thioflavin-S positive). During the scoring, any weak homogenously stained cell bodies were excluded from analysis to semi-quantify only dense inclusions.
Further details on mouse experiment methodology for this data can be found in the same original publications [34; 36] . It should be noted that data from timepoints up to 12 months postinjection [36] and the dataset obtained at 18 months post-injection [34] were quantified separately and some subregions were grouped differently. Thus, the datasets were not directly comparable, and so r, r, and p-values cannot be directly compared. Instead we observe that the pattern of results produced by comparing the 18-month dataset with our modeled predictions remains consistent with the suggested pattern of increasingly heavy involvement of anterograde transit along fiber tracts as a driver of syn inclusions propagation. We still include the 18month data with other quantified timepoints in Figure 5 as this is meant to be illustrative of the pattern of results we see. Our more in-depth analyses separate the data up to 12-months ( 
Mouse experiments and data collection for original dataset from intrastriatal injections of
PFFs. For striatal injections, human alpha-synuclein was purified and assembled into PFFs in house following previously published protocols [23; 50] . PFFs were thawed and sonicated as previously published [34; 36] . 4 week old OF1-Swiss mice were injected stereotactically 2ul of PFFs unilaterally into the dorsal striatum as previously described (striatum coordinates from bregma: AP; +0.2mm, ML:-2.0mm, DV: -2.6mm). Mice were euthanized 8 weeks post injection by deep anesthesia with sodium pentobarbital and perfused transcardially with 0.9% saline, then J o u r n a l P r e -p r o o f 9 4% paraformaldehyde (PFA) in phosphate buffer. We collected the brains and post-fixed them for 24 hours in 4% PFA. Brains were then stored in 30% sucrose in phosphate buffer at 4 ˚C until use. Brains were sectioned coronally into 40 um thick sections on a freezing microtome. Free floated sections were stored in cryoprotectant.
The following staining protocol and semiquantitative analyses were employed: Pser129 inclusions was semi-quantified across almost 40 regions, at one timepoint 8 weeks post-injection with in house recombinant human PFFs. The semi-quantification in this study was based on immunohistochemistry and followed the same procedure for converting IHC signal to semiquants as in [34; 36] . While this dataset is only cross-sectional rather than longitudinal, as it only contains one timepoint, it contains data from each individual mouse. With this dataset we accordingly assessed whether there was an identifiable directional predilection, according to our DNT modeling, in syn spread. The citation for this dataset can be found in [12] .
Mouse synucleinopathy datasets obtained from other sources (intra-nigral injections of fibrils).
To further investigate the propagation of abnormal inclusions in regards to theoretical propagation along axonal network, we chose to apply our connectivity model to another published dataset: Masuda-Suzukake, et al., 2013 [25] . Similar to our previous work [34; 36] , this study used immunohistochemistry as the basis for all quantifications or semi-quantifications and wild-type mice. In the study by Masuda-Suzukake et al., [25] mice were injected into the substantia nigra with recombinant syn fibrils, and at least 40 separate brain regions were quantified for syn inclusions. The investigators semi-quantitatively assessed syn pathology by grading regional severity out to 15 months post-injection using 3 months and 6 months as intermediary timepoints.
J o u r n a l P r e -p r o o f
Connectivity metrics, NT, and DNT. Connectivity metrics are calculated based on the topology of the mouse brain network derived from the MCA, where connectivity is represented as "outgoing" along the rows and "incoming" along the columns [28] . We generated a directed and weighted connectivity measure with seed regions by summing the weighted row-wise or columnwise values in the MCA at the seed nodes. We could then correlate each selected region's measured syn inclusions with its weighted connectivity, in both anterograde and retrograde directions, with the seed nodes in each study. Further information on using the MCA and its connectivity data for graph analyses can be found at the original citation [28] and in our prior paper using this atlas [26] .
NT and DNT modeling is similarly dependent on the MCA in this study, and on regional graph adjacency to the seed nodes or nodes already containing inclusions. We first calculate the Normalized Adjacency or Laplacian Matrix, L, given by the equation below:
where C is the connectivity matrix from the MCA, I is the identity matrix, and D R and D C are the row and column wise diagonal matrices from the MCA. Previous graph theoretic work has characterized diffusion over a network from defined seed points and has been shown to be predictive for both volumetric loss [16; 30] and metabolic dysfunction [31] in patients with AD or other tauopathic dementia, as well as for mouse models of tauopathy and amyloidopathy [26; 27] :
Here L is the Laplacian Matrix, βt is a constant representing diffusion time determined by when it maximizes R, which is the change in R-value from βt = 0 to maximum, X(0) is a vector with J o u r n a l P r e -p r o o f n number of nodes length representing seeding, and X(t) is a vector with n number of nodes length representing the final pattern of network diffusion. Further information on the derivation of the above equation and graph diffusion modeling can be found at the aforementioned citations.
In the present study, we use a modified version of the above NT model equation so that we could both capture the directionality information from the MCA allowing us to represent synucleinopathy as not only a process of spread but also of accumulation, analogous to a prionlike disorder. We captured the directionality information from the MCA by calculating different networks for each direction, where C represents the standard connectivity network, C T represents the network in the retrograde direction, and the summed connectivity of both, C + C T , represents the undirected network derived from the MCA. Here we use an integrative or summative approach to capture accumulation and so the equation can be represented in two manners:
More information on the mathematics behind this approach can be found in our previous work [26; 27; 31] . The Spatial diffusion model (SPD) uses the same Laplacian and model equation,
(2), from above; the difference between NT or DNT models and the SPD model is that the SPD model, as its network, instead utilizes the Cartesian distances, in voxels, between the centers of mass of any given region pair, rather than their axonal connectivity. To test for the effects of progression time on directional bias in syn propagation we correlated each measured timepoint's retrograde and anterograde bias, across all studies, and correlated that with the time of measurement (in months) after study initiation. We also correlated the bias difference scores, as calculated above, across timepoints. Because we present 24 total correlations, when assessing for significance, we corrected the -value threshold for significance, originally at p < 0.05, by dividing it by 24 to yield a significance cutoff at p < 0.002. We analyzed the striatal injection dataset from [12] using two-sample t-tests to compare rvalues across all data using anterograde versus retrograde biased DNT. All statistical analyses were performed using MatLab unless explicitly stated otherwise. We anatomically illustrate our anterograde DNT model's regional inclusions predictions and empirical data in Figure 2f . The SPD model continues to fail to produce any pattern that significantly matches empirical data.
Results
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We further analyzed the 18-month post-injection data and observed the same phenomenon of implied heavy involvement of anterograde direction fiber tract transit in mice injected with both mPFFs and huPFFs. As referred to in our note above, the R, R, and p-values at 18 months are not directly comparable with those from the other timepoints in our dataset, so we analyze and present the 18-months data separately. We found that anterograde DNT produces a significant, and the strongest, recreation of regional inclusions patterns in both mice injected with huPFFs, R = 0.64, p < 0.002 (Figure 4a (Figure 5c ).
Data using other injection sites suggests a similar pattern of early retrograde and later
anterograde spread involvement in interregional syn propagation. We first directly test whether there might be an initial retrograde bias in early post-injection syn inclusions, using the dataset obtained from the Masuda-Suzukake, et al., 2013 [25] publication and another dataset from one of our labs [12] . We find that in the dataset from [25] , at both 3 and 6 months postinjection, akin with similar timepoints post-injection from our own dataset (see above), there is a retrograde bias in how well DNT fits syn inclusions data. We further find that, in other data from one of our labs [12] , the spatial pattern of syn inclusions at only 8 weeks post-injection with fibrils, is best fit by retrograde DNT, p < 0.002, (Figure 6a ) using a two-sample t-test. Akin to results obtained using our own datasets, there is however a switch to a finding of anterograde bias in how well DNT fits syn pathology data by 15 months post-injection ( Figure 6b ). We subsequently used the data from [25] , to create an example illustration of the phenomenon of implied heavy and increasing anterograde direction fiber tract transit involvement in (Figure 6c ). We anatomically illustrate our results using data from the Masuda-Suzukake, et al., 2013, study in Figure 6d . More information on the dataset from [25] and the data from Patrik Brundin's lab used here can be obtained in the Mouse synucleinopathy dataset obtained from published source subsection of the Methods section. These results and their implications are further explored in the Discussion.
Discussion
Our results confirm that syn inclusions are likely to spread along axons and transsynaptically after triggering synucleinopathy by localized injection of syn fibrils. We also observed that both anterograde and retrograde syn propagation are possible. Our results suggest that syn inclusions spreading is directionally biased with a predominance of retrograde propagation first, and that the directional bias of syn pathology propagation changes over time.
Specifically, until 9 months post injection, a propagation model involving retrograde transport reproduces the pattern we observed in our animal experiments. In a second phase, 12 months post injection and later, a combination of retrograde and anterograde propagation explains the spatial pattern observed in vivo. A time-dependent directional bias can help explain why in human synucleinopathies some brain regions that are strongly connected to an affected brain area are spared early on, but not later, in the disease course.
We found that our mathematical model of anatomical spreading of syn inclusions applied well to both our own data from a mouse model involving syn PFFs injection into the olfactory bulb [34; 36] , as well as in mice where syn fibrils or PFFs were injected into either J o u r n a l P r e -p r o o f 18 the Substantia nigra [25] or striatum [12] . While we consistently observed a preferred retrograde spread early and anterograde spread late after injection of fibrils/ PFFs, we do imply that the directional switch we find here is a general rule. It is possible that the particular conformation of the initial seed of syn aggregates (i.e. specific syn "strains") and the anatomical region where the first seeding event takes place (e.g. olfactory bulb versus substantia nigra) will significantly influence the direction (antero-or retrograde) of spread. We discuss the relevance of this to both syn pathology in general and with regards to specific synucleinopathies (e.g. PD, DLB) in subsections below. pathological seeds. To use this connectome with our DNT modeling, we had to make several assumptions. We assumed that there are no brain-region specific biases in the transfer or uptake of their adenovirus tracer [28] and that uptake is therefore even, allowing for some noise, across all parts of the mouse brain. We also assumed that there is a directly proportional relationship between fluorescent signal from the viral tracer and the total number or volume of axonal tracts from the seeded to the signal region. As discussed in the ABI paper introducing the MCA [28] , these assumptions are unlikely to be true across the board, but are likely accurate enough at the coarse parcellation of a brain into 426 regions. Importantly, making these assumptions allows our model to simulate spread over the entire connectome.
Transsynaptic and fiber tract-based spread model replicates the
We demonstrate clear correspondence between regions most likely (based on neuronal connections) to exhibit pathology from the region where the initial seeding takes place (the olfactory bulb, substantia nigra, or striatum) and the regions that we found to contain syn inclusions in in vivo experiments [25; 34; 36] (Figures 2-5 ). To confirm that the fitting of the theoretical propagation pattern with the empirical in vivo data is not dependent on site of pathology-initiation, we analyzed previously published datasets using two different injection sites [25; 34; 36] . We found the same correspondence between our theoretical modeling of propagation and published data from [25] using with the substantia as initiation site. We further demonstrate retrograde DNT recreates spatial syn patterns [12] (Fig 6d) . We also tested whether a pattern of spread based on spatial, rather than connectome proximity to the seed region, would recapitulate syn patterns, implying potential active or passive extracellular spread of pathogenic protein aggregates. This analysis showed that spatial diffusion is not a predictor of syn inclusions localization in the two datasets we examined (Figures 2-6 ), and provides further support for the transsynaptic syn pathology spread hypothesis. direction, and that the preferential retrograde propagation is a generalized mechanism to all the brain regions each lab tested. In addition, the authors observed that the regional level of expression of syn influences strongly the vulnerability of a given brain region to develop syn What cellular mechanisms might contribute to change biases in directional spread over time? Prior work on transsynaptic syn propagation suggests that spread through a neural network in an anterograde direction might involve release of exosomes into the synaptic cleft [40] . However, retrograde spread can also occur, via release into the synaptic cleft from dendrites or soma, and possibly enter the presynaptic side via tunneling nanotubes or even receptor mediated internalization [45] . For network spread to occur bidirectionally, both transsynaptic propagation and axonal transport/diffusion of syn must be bidirectional, assumptions that are supported by cell culture and microfluidic studies [39; 43; 49] .
Interestingly, syn can interfere with the net directionality of axonal transport by its interaction with kinesin and dynein motors [39; 49] , and thereby affect directional bias.
We speculate that biased spread influences spatiotemporal development of syn pathology and partly explains why some regions exhibit syn inclusions while others do not. The 45]. In DLB, syn aggregates are frequently seen in olfactory structures as well as limbic system [2] .
Our work posits not only directional biases in syn spread, but a directional switch in these biases (Figures 2-6 ). Syn can interact with both anterograde direction kinesin and J o u r n a l P r e -p r o o f 22 retrograde direction dynein axonal transport protein families [3] . Importantly, syn misfolding appears to decrease its anterograde transport by kinesin proteins, and increase its retrograde transport by dynein proteins [51] by at latest 8 weeks post-aggregation initiation. This could explain an early retrograde bias in syn propagation that shifts to either bidirectional or anterograde syn spread as syn inclusions progress. Because both the substantia nigra and olfactory areas have dense connections with the striatum [28] , the relative sparsity of syn aggregates in the striatum in PD might be viewed as unexpected. However, if transsynaptic syn spread is predominantly in the retrograde direction early in disease course (Figures 2-6 ), we would indeed not expect early pronounced syn inclusions accumulation in the striatum because most of the connections between the injected olfactory bulb and the striatum are afferents to the striatum [28] .
Assumptions and limitations.
There are limitations of our model and of our datasets. First, our DNT modeling rely on several assumptions so we could model the spread over the entire connectome (we assumed that the uptake of adenovirus tracer is even in the brain, and assume that the tracers fluorescent signal is proportional to the volume of axonal tracts containing fluorescent signal). As mentioned earlier and as discussed in previous work [28] , our assumptions are likely accurate enough for the parcellation in 426 brain regions we are using here.
In addition, the model does not consider region-specific factors that may influence the susceptibility of regions to become 'infected' by pathogenic syn. Therefore, our model does not consider region-specific factors which can influence an area's susceptibility to develop inclusions, regardless of spread, a concern other recent work investigating syn inclusion spread J o u r n a l P r e -p r o o f 23 notes [22] . Our model also does not reflect that neurons might die, due to aggregates forming, in some brain regions, and therefore neither updates the connectome to account for loss of white matter nor updates the model to account for loss of syn that dead neurons once contained.
Uneven antibody penetrance between mice could potentially confound data. There are also limitations regarding our dataset because it is only semi-quantitative [34; 36] . However, in our long-term study [34] , we performed densitometry analysis of pser129 inclusions on a restricted number of brain regions, in addition to our semi-quantitative analysis, and the results from both method were consistent indicating that our semi-quantitative analysis using scores reflects well the density of inclusions present in a given brain region. Finally, cellular inflammatory and excocytosis responses that occur in response to injection with -synuclein fibrils could affect spread processes for -synuclein inclusions at timepoints closest to injection. The fit of the DNT model at 3-months post-injection is worse than at any other timepoint, potentially indicating injection-response cellular processes as a limitation for how well a spread or diffusion model can fit data at timepoints close to injection.
Additionally of note, some technical aspects differs between the different datasets. We performed injections into the olfactory bulb in 7-8 weeks old C57/Bl6 mice, while Masuda-Suzukake and coworkers [25] injected older mice of the same strains. Regarding our intrastriatal injections, we injected 4 week-old mice of a different background strain (OF1mice). The fibrils used for each dataset were different or produced by different labs: for olfactory bulb injections, mPFFs and huPFFs were produced by K. Luk while huPFFs used for striatal injections were produced in our lab (following K Luk's published protocol) [50] ; and Masuda-Suzukake's fibrils were produced following a different protocol in their own lab [25] . Thus, it is possible that these J o u r n a l P r e -p r o o f 24 different assemblies have different seeding and propagation capacities. Despite these differences, our results demonstrate similar propagation characteristics in the three different datasets.
Concluding remarks.
In conclusion, we provide evidence that the propagation of synucleinopathy in fibril-injection mouse models occurs via neural network and transsynaptically. Our findings in mice support the hypothesis by Braak and colleagues of propagation of syn pathology via neuronal networks in humans [4; 5; 6; 7; 8; 15] . In addition, we demonstrate that the preferred direction of syn inclusions propagation is initially retrograde, and becomes anterograde at several months post injection, indicating that the preferred direction can switch over time. (c) Example of a βt-curve showing r-value across βt parameter values for predictive (peak at βt > 0) and non-predictive models (peak at βt = 0). (d) A color legend and brain showing the color scheme, by major region, for all the balls depicting regions in all anatomical illustrations of mouse brains throughout the rest of the paper. The dot sizes correspond to randomly generated "example" or "pseudo" inclusions amounts, per-region, where each dot represents one region in its center of mass. In anatomic illustrations of this nature with actual results, the inclusions amounts will not be random, but will rather be determined by inclusions severity recorded from data or predicted by a given NT model. Figure 1 for color legend for the major region color scheme of the balls denoting regional syn inclusions. The red arrow points toward the MOB where the PFFs were injected. Significance level: + p < 0.01, * p < 0.02 months post injection and the corresponding anterograde-DNT simulation. All data and NT simulation values are log-transformed prior to both statistics and anatomical visualizations. AMY = amygdala, AOB = accessory olfactory bulb, AON = anterior olfactory nucleus, DG = dentate gyrus, ENT = entorhinal cortex, MOB = main olfactory bulb, PIR = piriform cortex, SUB = subiculum, TT = tenia tecta. Please see Figure 1 for color legend for the major region color scheme of the balls denoting regional syn inclusions. The red arrow points toward the MOB where the PFFs were injected. + p < 0.01, * p < 0.02 Figure 4 . At 18-months post injection, we find the same phenomenon of strong inclusion pattern recreation by our anterograde DNT model at timepoints far from injection, and in contrast with findings at earlier measured timepoints. (a) βt-curve showing NT models' r-value with huPFF data at 18-months post-injection at different diffusion time constants. (b) Scatterplots for each model's prediction at the βt diffusion rate constant that maximizes r-values with regional syn inclusion data from huPFF injected mice. (c) An anatomical illustration of regional syn inclusion pattern data and anterograde and retrograde DNT model predictions for huPFF injected mice. (d) βt-curve showing NT models' r-value with mPFF data at 18-months post-injection at different diffusion time constants. (e) Scatterplots for each model's prediction at the βt diffusion rate constant that maximizes r-values with regional syn inclusion data from mPFF injected mice. (f) An anatomical illustration of regional syn inclusion pattern data and anterograde and retrograde DNT model predictions for mPFF injected mice. AMY = amygdala, AOB = accessory olfactory bulb, AON = anterior olfactory nucleus, DG = dentate gyrus, ENT = entorhinal cortex, MOB = main olfactory bulb, NAcc = nucleus accumbens, PIR = piriform cortex, SUB = subiculum, TT = tenia tecta. Please see Figure 1 for color legend for the major region color scheme of the balls denoting regional syn inclusions. The red arrow points toward the MOB where the PFFs were injected. + p < 0.01, * p < 0.02 Figure 5 . DNT retrograde models are better predictors of synuclein inclusions closer to initial pathological injection, but anterograde DNT is a better predictor of synuclein inclusions as more time elapses following injection. (a) mPFF synuclein injected mice and (b) huPFF synuclein injected mice both show spatiotemporal synucleinopathy development such that at times closer to the initial injection, retrograde DNT is the best predictor, but at times farther from the injection, anterograde DNT better recapitulates syn inclusion spread than does retrograde DNT. (c) Calculated directional bias in the fit with data between anterograde and retrograde DNT models shifts towards anterograde DNT over time. A reference line at 0, the value at which there should be no directional bias, is added to the plot in (c). All data and NT simulation values are log-transformed prior to running statistics. Figure 6 . Datasets using other injection sites show the same directional shift as our data: that at timepoints surrounding the injection, synuclein inclusions are better explained by a model positing retrograde spread, but at timepoints farther form the injection, models using anterograde spread perform better. (a) Another dataset from Patrik Brundin's lab [12] using mice injected with fibrils into the striatum with regional quantification at 8-weeks post injection show the same pattern, regardless of genotype, as this early post-injection quantification of syn inclusions is best fit by retrograde DNT. The next panels (b,c, d) use data from [24] : (b) Anterograde bias, 
